Analystreport

Viking Therapeutics Inc (NASDAQ: VKTX) is now covered by analysts at Chardan Capital. They set a "buy" rating and a $15.00 price target on the stock.

Viking Therapeutics, Inc.  (VKTX) 
Last viking therapeutics, inc. earnings: 4/30 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.vikingtherapeutics.com